American Journal of Kidney Diseases

Sudden Cardiac Death Among Hemodialysis Patients

Published:February 17, 2017DOI:
      Hemodialysis patients carry a large burden of cardiovascular disease; most onerous is the high risk for sudden cardiac death. Defining sudden cardiac death among hemodialysis patients and understanding its pathogenesis are challenging, but inferences from the existing literature reveal differences between sudden cardiac death among hemodialysis patients and the general population. Vascular calcifications and left ventricular hypertrophy may play a role in the pathophysiology of sudden cardiac death, whereas traditional cardiovascular risk factors seem to have a more muted effect. Arrhythmic triggers also differ in this group as compared to the general population, with some arising uniquely from the hemodialysis procedure. Combined, these factors may alter the types of terminal arrhythmias that lead to sudden cardiac death among hemodialysis patients, having important implications for prevention strategies. This review highlights current knowledge on the epidemiology, pathophysiology, and risk factors for sudden cardiac death among hemodialysis patients. We then examine strategies for prevention, including the use of specific cardiac medications and device-based therapies such as implantable defibrillators. We also discuss dialysis-specific prevention strategies, including minimizing exposure to low potassium and calcium dialysate concentrations, extending dialysis treatment times or adding sessions to avoid rapid ultrafiltration, and lowering dialysate temperature.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Saran R.
        • Li Y.
        • Robinson B.
        • et al.
        US Renal Data System 2014 Annual Data Report: epidemiology of kidney disease in the United States.
        Am J Kidney Dis. 2015; 66
        • Jadoul M.
        • Thumma J.
        • Fuller D.S.
        • et al.
        Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
        Clin J Am Soc Nephrol. 2012; 7: 765-774
        • Hinkle Jr., L.E.
        • Thaler H.T.
        Clinical classification of cardiac deaths.
        Circulation. 1982; 65: 457-464
        • Mann D.L.
        • Zipes D.P.
        • Libby P.
        • Bonow R.O.
        • Braunwald E.
        Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.
        10th ed. Elsevier/Saunders, Philadelphia, PA2015 (Accessed December 5, 2016)
        • Herzog C.A.
        • Asinger R.W.
        • Berger A.K.
        • et al.
        Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
        Kidney Int. 2011; 80: 572-586
        • Mozaffarian D.
        • Benjamin E.J.
        • Go A.S.
        • et al.
        • Writing Group Members
        Heart disease and stroke statistics-2016 update: a report from the American Heart Association.
        Circulation. 2016; 133: e38-e360
        • Takeda K.
        • Harada A.
        • Okuda S.
        • et al.
        Sudden death in chronic dialysis patients.
        Nephrol Dial Transplant. 1997; 12: 952-955
        • Herzog C.A.
        Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome.
        Kidney Int Suppl. 2003; 84: S197-S200
        • Bleyer A.J.
        • Hartman J.
        • Brannon P.C.
        • Reeves-Daniel A.
        • Satko S.G.
        • Russell G.
        Characteristics of sudden death in hemodialysis patients.
        Kidney Int. 2006; 69: 2268-2273
        • Ramesh S.
        • Zalucky A.
        • Hemmelgarn B.R.
        • et al.
        Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis.
        BMC Nephrol. 2016; 17: 78
        • Pun P.H.
        • Herzog C.A.
        • Middleton J.P.
        Improving ascertainment of sudden cardiac death in patients with end stage renal disease.
        Clin J Am Soc Nephrol. 2012; 7: 116-122
        • Cheung A.K.
        • Sarnak M.J.
        • Yan G.
        • et al.
        Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.
        Kidney Int. 2004; 65: 2380-2389
        • Wanner C.
        • Krane V.
        • Marz W.
        • et al.
        Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
        N Engl J Med. 2005; 353: 238-248
        • Wheeler D.C.
        • London G.M.
        • Parfrey P.S.
        • et al.
        Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
        J Am Heart Assoc. 2014; 3: e001363
        • Rocco M.V.
        • Yan G.
        • Gassman J.
        • et al.
        Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.
        Am J Kidney Dis. 2002; 39: 146-153
        • Huikuri H.V.
        • Castellanos A.
        • Myerburg R.J.
        Sudden death due to cardiac arrhythmias.
        N Engl J Med. 2001; 345: 1473-1482
        • Bayes de Luna A.
        • Coumel P.
        • Leclercq J.F.
        Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases.
        Am Heart J. 1989; 117: 151-159
        • Priori S.G.
        • Blomstrom-Lundqvist C.
        • Mazzanti A.
        • et al.
        2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
        Eur Heart J. 2015; 36: 2793-2867
        • Ohtake T.
        • Kobayashi S.
        • Moriya H.
        • et al.
        High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination.
        J Am Soc Nephrol. 2005; 16: 1141-1148
        • Lowrie E.G.
        • Lew N.L.
        Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities.
        Am J Kidney Dis. 1990; 15: 458-482
        • Kalantar-Zadeh K.
        • Block G.
        • Humphreys M.H.
        • Kopple J.D.
        Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
        Kidney Int. 2003; 63: 793-808
        • Zager P.G.
        • Nikolic J.
        • Brown R.H.
        • et al.
        “U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.
        Kidney Int. 1998; 54: 561-569
        • Pun P.H.
        • Smarz T.R.
        • Honeycutt E.F.
        • Shaw L.K.
        • Al-Khatib S.M.
        • Middleton J.P.
        Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease.
        Kidney Int. 2009; 76: 652-658
        • Genovesi S.
        • Valsecchi M.G.
        • Rossi E.
        • et al.
        Sudden death and associated factors in a historical cohort of chronic haemodialysis patients.
        Nephrol Dial Transplant. 2009; 24: 2529-2536
        • Yamada S.
        • Ishii H.
        • Takahashi H.
        • et al.
        Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.
        Clin J Am Soc Nephrol. 2010; 5: 1793-1798
        • Mangrum A.J.
        • Liu D.
        • Dimarco J.P.
        • Bolton K.
        • Mangrum M.
        Sudden cardiac death and left ventricular function in hemodialysis patients.
        Heart Rhythm. 2005; 2: S33
        • Paoletti E.
        • Specchia C.
        • Di Maio G.
        • et al.
        The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
        Nephrol Dial Transplant. 2004; 19: 1829-1834
        • Mark P.B.
        • Johnston N.
        • Groenning B.A.
        • et al.
        Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
        Kidney Int. 2006; 69: 1839-1845
        • Schietinger B.J.
        • Brammer G.M.
        • Wang H.
        • et al.
        Patterns of late gadolinium enhancement in chronic hemodialysis patients.
        JACC Cardiovasc Imaging. 2008; 1: 450-456
        • Amann K.
        • Breitbach M.
        • Ritz E.
        • Mall G.
        Myocyte/capillary mismatch in the heart of uremic patients.
        J Am Soc Nephrol. 1998; 9: 1018-1022
        • Burton J.O.
        • Jefferies H.J.
        • Selby N.M.
        • McIntyre C.W.
        Hemodialysis-induced cardiac injury: determinants and associated outcomes.
        Clin J Am Soc Nephrol. 2009; 4: 914-920
        • Foley R.N.
        • Gilbertson D.T.
        • Murray T.
        • Collins A.J.
        Long interdialytic interval and mortality among patients receiving hemodialysis.
        N Engl J Med. 2011; 365: 1099-1107
        • Wong M.C.
        • Kalman J.M.
        • Pedagogos E.
        • et al.
        Temporal distribution of arrhythmic events in chronic kidney disease: highest incidence in the long interdialytic period.
        Heart Rhythm. 2015; 12: 2047-2055
        • Krishnasamy R.
        • Badve S.V.
        • Hawley C.M.
        • et al.
        Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.
        Am J Kidney Dis. 2013; 61: 96-103
        • Pun P.H.
        • Lehrich R.W.
        • Honeycutt E.F.
        • Herzog C.A.
        • Middleton J.P.
        Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics.
        Kidney Int. 2011; 79: 218-227
        • Karnik J.A.
        • Young B.S.
        • Lew N.L.
        • et al.
        Cardiac arrest and sudden death in dialysis units.
        Kidney Int. 2001; 60: 350-357
        • Movilli E.
        • Gaggia P.
        • Zubani R.
        • et al.
        Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study.
        Nephrol Dial Transplant. 2007; 22: 3547-3552
        • Saran R.
        • Bragg-Gresham J.L.
        • Levin N.W.
        • et al.
        Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.
        Kidney Int. 2006; 69: 1222-1228
        • Flythe J.E.
        • Brunelli S.M.
        The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care.
        Semin Dial. 2011; 24: 259-265
        • Gabutti L.
        • Ferrari N.
        • Giudici G.
        • Mombelli G.
        • Marone C.
        Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis.
        Nephrol Dial Transplant. 2003; 18: 2369-2376
        • Di Iorio B.
        • Torraca S.
        • Piscopo C.
        • et al.
        Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects.
        J Nephrol. 2012; 25: 653-660
        • Pande S.
        • Raja R.
        • Bloom E.
        • Chewaproug D.
        • Dissanayake I.
        Effect of dialysate baths on serum bicarbonate levels in hemodialysis patients.
        Am J Kidney Dis. 2011; 57 ([abstract]): A75
        • Chan K.E.
        • Newton-Cheh C.
        • Gusella J.F.
        • Maddux F.W.
        Heritability of risk for sudden cardiac arrest in ESRD.
        J Am Soc Nephrol. 2015; 26: 2815-2820
        • Spooner P.M.
        Sudden cardiac death: the larger problem… The larger genome.
        J Cardiovasc Electrophysiol. 2009; 20: 585-596
        • Keller S.P.
        • Halperin H.R.
        Cardiac arrest: the changing incidence of ventricular fibrillation.
        Curr Treat Options Cardiovasc Med. 2015; 17: 392
        • Bonato F.O.
        • Lemos M.M.
        • Cassiolato J.L.
        • Canziani M.E.
        Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients.
        PLoS One. 2013; 8: e66036
        • Hsueh C.-H.C.
        • Neal X.
        • Chen P.-S.
        • Lin S.F.
        • Moe S.M.
        Increased inducibility of ventricular arrhythmia in a rat model of chronic kidney disease.
        J Am Soc Nephrol. 2013; 24 ([abstract]): 139A
        • Wan C.
        • Herzog C.A.
        • Zareba W.
        • Szymkiewicz S.J.
        Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator.
        Ann Noninvasive Electrocardiol. 2014; 19: 247-257
        • Davis T.R.
        • Young B.A.
        • Eisenberg M.S.
        • Rea T.D.
        • Copass M.K.
        • Cobb L.A.
        Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers.
        Kidney Int. 2008; 73: 933-939
        • Lafrance J.P.
        • Nolin L.
        • Senecal L.
        • Leblanc M.
        Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period.
        Nephrol Dial Transplant. 2006; 21: 1006-1012
        • Verde E.
        • Perez de Prado A.
        • Lopez-Gomez J.M.
        • et al.
        Asymptomatic intradialytic supraventricular arrhythmias and adverse outcomes in patients on hemodialysis.
        Clin J Am Soc Nephrol. 2016; 11: 2210-2217
        • Charytan D.M.
        • Foley R.
        • McCullough P.A.
        • et al.
        Arrhythmia and sudden death in hemodialysis patients: protocol and baseline characteristics of the Monitoring in Dialysis Study.
        Clin J Am Soc Nephrol. 2016; 11: 721-734
      1. Roy-Chaudhury P, Williamson DE, Tumlin JA, et al. Monitoring in Dialysis (MiD) Study: exploring the timeline and etiology of increased arrhythmias in hemodialysis (HD) patients. Society of Nephrology Kidney Week 2015. San Diego, November 3-8, 2015.

        • Pun P.H.
        • Lehrich R.W.
        • Smith S.R.
        • Middleton J.P.
        Predictors of survival after cardiac arrest in outpatient hemodialysis clinics.
        Clin J Am Soc Nephrol. 2007; 2: 491-500
        • Kudenchuk P.J.
        • Stuart R.
        • Husain S.
        • Fahrenbruch C.
        • Eisenberg M.
        Treatment and outcome of out-of-hospital cardiac arrest in outpatient health care facilities.
        Resuscitation. 2015; 97: 97-102
        • Ganesh S.K.
        • Stack A.G.
        • Levin N.W.
        • Hulbert-Shearon T.
        • Port F.K.
        Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.
        J Am Soc Nephrol. 2001; 12: 2131-2138
        • Parekh R.S.
        • Plantinga L.C.
        • Kao W.H.
        • et al.
        The association of sudden cardiac death with inflammation and other traditional risk factors.
        Kidney Int. 2008; 74: 1335-1342
        • Drechsler C.
        • Krane V.
        • Winkler K.
        • Dekker F.W.
        • Wanner C.
        Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients.
        Kidney Int. 2009; 76: 567-575
        • Shastri S.
        • Tangri N.
        • Tighiouart H.
        • et al.
        Predictors of sudden cardiac death: a competing risk approach in the Hemodialysis Study.
        Clin J Am Soc Nephrol. 2012; 7: 123-130
        • Passman R.
        • Herzog C.A.
        End-stage renal disease: sudden cardiac death: stratifying risk in dialysis patients.
        Nat Rev Nephrol. 2011; 7: 133-135
        • Domanski M.J.
        • Zipes D.P.
        • Schron E.
        Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions.
        Circulation. 1997; 95: 2694-2699
        • Cice G.
        • Ferrara L.
        • D'Andrea A.
        • et al.
        Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.
        J Am Coll Cardiol. 2003; 41: 1438-1444
        • Agarwal R.
        • Sinha A.D.
        • Pappas M.K.
        • Abraham T.N.
        • Tegegne G.G.
        Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.
        Nephrol Dial Transplant. 2014; 29: 672-681
        • Tangri N.
        • Shastri S.
        • Tighiouart H.
        • et al.
        beta-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study.
        Am J Kidney Dis. 2011; 58: 939-945
        • Fellstrom B.
        • Zannad F.
        • Schmieder R.
        • et al.
        Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.
        Curr Control Trials Cardiovasc Med. 2005; 6: 9
        • Baigent C.
        • Landray M.J.
        • Reith C.
        • et al.
        The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
        Lancet. 2011; 377: 2181-2192
        • Iseki K.
        • Arima H.
        • Kohagura K.
        • et al.
        Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial.
        Nephrol Dial Transplant. 2013; 28: 1579-1589
        • Zannad F.
        • Kessler M.
        • Lehert P.
        • et al.
        Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
        Kidney Int. 2006; 70: 1318-1324
        • Tai D.J.
        • Lim T.W.
        • James M.T.
        • Manns B.J.
        • Tonelli M.
        • Hemmelgarn B.R.
        Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis.
        Clin J Am Soc Nephrol. 2010; 5: 623-630
        • Matsumoto Y.
        • Mori Y.
        • Kageyama S.
        • et al.
        Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients.
        J Am Coll Cardiol. 2014; 63: 528-536
        • Santoro A.
        • Mancini E.
        • London G.
        • et al.
        Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal.
        Nephrol Dial Transplant. 2008; 23: 1415-1421
        • Weir M.R.
        • Bakris G.L.
        • Bushinsky D.A.
        • et al.
        Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
        N Engl J Med. 2015; 372: 211-221
        • Kosiborod M.
        • Peacock W.F.
        • Packham D.K.
        Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia.
        N Engl J Med. 2015; 372: 1577-1578
        • Beaubien E.R.
        • Pylypchuk G.B.
        • Akhtar J.
        • Biem H.J.
        Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality.
        Am J Kidney Dis. 2002; 39: 834-842
        • Pun P.H.
        • Horton J.R.
        • Middleton J.P.
        Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients.
        Clin J Am Soc Nephrol. 2013; 8: 797-803
        • Brunelli S.M.
        • Sibbel S.
        • Do T.P.
        • Cooper K.
        • Bradbury B.D.
        Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study.
        Am J Kidney Dis. 2015; 66: 655-665
        • Kim E.D.
        • Parekh R.S.
        Calcium and sudden cardiac death in end-stage renal disease.
        Semin Dial. 2015; 28: 624-635
        • Di Lullo L.
        • Rivera R.
        • Barbera V.
        • et al.
        Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies.
        Int J Cardiol. 2016; 217: 16-27
        • Flythe J.E.
        • Kimmel S.E.
        • Brunelli S.M.
        Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.
        Kidney Int. 2011; 79: 250-257
        • Mendoza J.M.
        • Bayes L.Y.
        • Sun S.
        • Doss S.
        • Schiller B.
        Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study.
        Am J Kidney Dis. 2011; 58: 956-963
        • Jefferies H.J.
        • Burton J.O.
        • McIntyre C.W.
        Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability.
        Blood Purif. 2011; 32: 63-68
        • Odudu A.
        • Eldehni M.T.
        • McCann G.P.
        • McIntyre C.W.
        Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients.
        Clin J Am Soc Nephrol. 2015; 10: 1408-1417
        • The FHN Trial Group
        In-center hemodialysis six times per week versus three times per week.
        N Engl J Med. 2010; 363: 2287-2300
        • Eckart R.E.
        • Gula L.J.
        • Reynolds M.R.
        • Shry E.A.
        • Maisel W.H.
        Mortality following defibrillator implantation in patients with renal insufficiency.
        J Cardiovasc Electrophysiol. 2006; 17: 940-943
        • Wase A.
        • Basit A.
        • Nazir R.
        • et al.
        Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients.
        J Interv Card Electrophysiol. 2004; 11: 199-204
        • Robin J.
        • Weinberg K.
        • Tiongson J.
        • et al.
        Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
        Heart Rhythm. 2006; 3: 1196-1201
        • Sakhuja R.
        • Keebler M.
        • Lai T.S.
        • McLaughlin Gavin C.
        • Thakur R.
        • Bhatt D.L.
        Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.
        Am J Cardiol. 2009; 103: 735-741
        • Dasgupta A.
        • Montalvo J.
        • Medendorp S.
        • et al.
        Increased complication rates of cardiac rhythm management devices in ESRD patients.
        Am J Kidney Dis. 2007; 49: 656-663
        • Pun P.H.
        • Hellkamp A.S.
        • Sanders G.D.
        • et al.
        Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
        Nephrol Dial Transplant. 2015; 30: 829-835
        • Pun P.H.
        • Al-Khatib S.M.
        • Han J.Y.
        • et al.
        Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
        Am J Kidney Dis. 2014; 64: 32-39
        • Drew D.A.
        • Meyer K.B.
        • Weiner D.E.
        Transvenous cardiac device wires and vascular access in hemodialysis patients.
        Am J Kidney Dis. 2011; 58: 494-496
        • Teruya T.H.
        • Abou-Zamzam Jr., A.M.
        • Limm W.
        • Wong L.
        • Wong L.
        Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers.
        Ann Vasc Surg. 2003; 17: 526-529
        • Dhamija R.K.
        • Tan H.
        • Philbin E.
        • et al.
        Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections.
        Am J Kidney Dis. 2015; 66: 154-158
        • Charytan D.M.
        • Patrick A.R.
        • Liu J.
        • et al.
        Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
        Am J Kidney Dis. 2011; 58: 409-417
        • Koman E.
        • Gupta A.
        • Subzposh F.
        • Saltzman H.
        • Kutalek S.P.
        Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
        J Interv Card Electrophysiol. 2016; 45: 219-223
        • El-Chami M.F.
        • Levy M.
        • Kelli H.M.
        • et al.
        Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis.
        J Cardiovasc Electrophysiol. 2015; 26: 900-904
      2. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative (KDOQI) Guideline 8: External Defibrillation. 2005; Accessed August 15, 2016.

        • Lehrich R.W.
        • Pun P.H.
        • Tanenbaum N.D.
        • Smith S.R.
        • Middleton J.P.
        Automated external defibrillators and survival from cardiac arrest in the outpatient hemodialysis clinic.
        J Am Soc Nephrol. 2007; 18: 312-320
        • Herzog C.A.
        • Li S.
        • Weinhandl E.D.
        • Strief J.W.
        • Collins A.J.
        • Gilbertson D.T.
        Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators.
        Kidney Int. 2005; 68: 818-825
        • Hiremath S.
        • Punnam S.R.
        • Brar S.S.
        • et al.
        Implantable defibrillators improve survival in end-stage renal disease: results from a multi-center registry.
        Am J Nephrol. 2010; 32: 305-310
        • Pun P.H.
        The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.
        Adv Chronic Kidney Dis. 2014; 21: 480-488